Vimarsana
Biggest News Aggregation in the World

Page 4 - Bymark Leiser News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bymark Leiser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bymark Leiser Today - Breaking & Trending Today

Some patients with stage III melanoma can avoid surgery after neoadjuvant immunotherapy - Vimarsana News

Some patients with stage III melanoma can avoid surgery after neoadjuvant immunotherapy

CHICAGO — Tumor lymph node dissection likely can be omitted for patients with melanoma who achieve major pathologic response after neoadjuvant immune checkpoint blockade, according to study results presented at ASCO Annual Meeting.Patients who achieve major pathologic response do not need adjuvant systemic therapy; however, adjuvant systemic therapy appears to extend survival for patients

Source: healio.com
Surgeon general: Burnout has many health care workers 'in crisis' - Vimarsana News

Surgeon general: Burnout has many health care workers 'in crisis'

CHICAGO — The escalating prevalence of burnout among U.S. health care providers poses “a real threat” to public health, the U.S. surgeon general told ASCO Annual Meeting attendees.“Many of our health care workers are in crisis,” Vice Admiral Vivek H. Murthy, MD, MBA, said during the meeting’s opening ceremony. “We have burnout rates that have gone through

Source: healio.com
Chemotherapy after first-line EGFR TKI fails to extend survival in advanced NSCLC - Vimarsana News

Chemotherapy after first-line EGFR TKI fails to extend survival in advanced NSCLC

CHICAGO — Platinum-doublet chemotherapy did not extend survival for patients with advanced nonsquamous non-small cell lung cancer who responded to EGFR tyrosine kinase inhibitor therapy, according to randomized phase 3 study results.The regimen prolonged PFS but did not confer an OS benefit, findings presented at ASCO Annual Meeting showed.

Source: healio.com
Glasgow prognostic score may predict survival in small cell lung cancer - Vimarsana News

Glasgow prognostic score may predict survival in small cell lung cancer

Glasgow prognostic score appeared associated with survival among patients with small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide, according to study results.No biomarkers are available to predict effectiveness of first-line therapy with atezolizumab (Tecentriq, Genentech) — an anti-PD-L1 antibody — plus carboplatin and etoposide for patients

Source: healio.com
AYA cancer survivors treated with cardiotoxic therapies exhibit accelerated cardiac aging - Vimarsana News

AYA cancer survivors treated with cardiotoxic therapies exhibit accelerated cardiac aging

Adolescent and young adult cancer survivors who received cardiotoxic treatments exhibited a high burden of poor cardiac function, according to study results presented at American Association for Cancer Research Annual Meeting. The cross-sectional study included 127 cancer survivors treated with anthracyclines or radiation for Hodgkin lymphoma or sarcoma as adolescents or young adults (AYA).

Source: healio.com